NCT Number: NCT06809439
Periodontitis is a multifactorial, chronic inflammatory disease caused by many factors such as pathogenic microorganisms, host response, environmental and systemic factors. Immune mechanisms triggered by host-bacteria interaction can initiate tissue destruction by leading to the release of large amounts of inflammatory mediators such as IL-1β. It is thought that IL-10 has a regulatory role by limiting the initiation and progression of the acute inflammatory response with its anti-inflammatory effect. The high detection of RANKL and RANKL/OPG ratios in periodontitis indicates that these markers play a role in bone destruction. Elucidating the connections between the immune system and bone-related cytokines will contribute significantly to the resolution of these complex mechanisms underlying periodontal diseases. Risk factors for periodontal diseases include gender, age, smoking and some hereditary factors. Cortisol is an important marker of psychological stress. It is emphasized that stress and depression reduce immune system function and cause chronic inflammation. Thus, it indirectly provokes periodontal tissue destruction.
Looking for future studies?
Notify Me35 year–60 year
All sexes
Interventional
Not applicable
AnkaraUniversity, Ankara, Turkey (Türkiye)
This study consists of patients and healthy volunteers. Saliva will be collected only once from healthy volunteers; from patients at the beginning and after non-surgical periodontal treatments are performed by the researchers. In the collected saliva; clinical parameters and salivary RANKL, OPG, IL-10, IL-1β, cortisol levels will be determined in periodontitis and periodontally healthy individuals living in two different geographical regions in Turkey (Ankara -Erzurum); it will be determined whether non-surgical periodontal treatment has an effect on cytokines determined in saliva and clinical status at the end of 1-month follow-up period; periodontal pathogenesis and host response will be evaluated in smoker and non-smoker groups. Analyses will be performed by ELISA method.
The study is based on the hypothesis that "different regional and geographical conditions determining climate, culture, environment, life, stress situations affect the course of periodontitis disease and host response". A regional comparison will be made between markers that affect the course of periodontitis disease and play a role in its pathogenesis in patients with different climate, living and cultural conditions, according to location.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Oral hygiene instructions including tooth brushing, flossing, and interdental brushing were given to all patient groups before non-surgical periodontal treatment. In both periodontitis groups, scaling, and root surface smoothing were performed using ultrasonic instruments (Woodpecker Medicals Ins. Co., USA) and Gracey Curettes (Hu-Friedy, Chicago, IL, USA) under local anesthesia once a week for 4 weeks.
Unstimulated saliva samples were collected from all participants between 9:00 and 11:00 am. Clinical periodontal measurements were performed after saliva collection to prevent contamination (bleeding, etc.). Participants refrained from brushing their teeth the morning before sampling and from eating, drinking, or smoking for at least 2 hours before sampling. Patients were asked to rinse their mouths with distilled water 5 minutes before saliva collection. A saliva sample was then collected by spitting directly into a sterile tube. Sample collection was continued for 5 minutes.
Clinical and radiographic evaluations were performed by trained and calibrated examiners at Ankara University (SY) and Ataturk University (OT). Clinical parameters of probing depth (PPD), clinical attachment level CAL, plaque index PI, and bleeding on probing (BOP) were recorded from six tooth regions (mesio-buccal, mid-buccal, disto-buccal, mesio-lingual, middle lingual, and disto-lingual) using periodontal probe. Bone loss was assessed using panoramic radiographs, confirming the diagnosis of periodontitis.
Unstimulated saliva samples were collected from all participants between 9:00 and 11:00 am. Clinical periodontal measurements were performed after saliva collection to prevent contamination (bleeding, etc.). Participants refrained from brushing their teeth the morning before sampling and from eating, drinking, or smoking for at least 2 hours before sampling. Patients were asked to rinse their mouths with distilled water 5 minutes before saliva collection. A saliva sample was then collected by spitting directly into a sterile tube. Sample collection was continued for 5 minutes.
Time frame: up to 4 weeks
This study included 10 systemically healthy non-smokers from Ankara with stage III, grade B generalized periodontitis, 8 smokers with stage III, grade C generalized periodontitis, 11 periodontally healthy non-smokers, and 11 periodontally healthy smokers. In Erzurum, systemically healthy, 9 non-smokers, stage III B generalized periodontitis , 6 smokers (≥10/day), stage III C generalized periodontitis, 11 periodontally healthy non-smokers, and 11 periodontally healthy smokers were included. Clinical parameters of probing depth (PPD), clinical attachment level (CAL), plaque index (PI), and bleeding on probing (BOP) were recorded . All clinical measurements were made after saliva samples were taken and recorded as initial values. The periodontal index form was used for this purpose. (https://www.periodontalchart-online.com/uk/) Nonsurgical periodontal treatments lasted 4 weeks. Baseline and post-treatment periodontal parameters were compared.
Time frame: up to 2 months
Saliva IL-1β (pg/ml), cortisol (ng/ml), RANKL (pg/ml), OPG(ng/ml), and IL-10 (pg/ml) concentrations were assessed via ELISA. The baseline saliva of the control groups and the pre- and post-treatment salivary biochemical parameters of the treatment groups were similar in both cities evaluated.
Time frame: up to 4 weeks
Williams periodontal probe was used to determine pocket depth. Care was taken to use the probe parallel to the long axis of the tooth with its own weight during the measurements.
PD was measured from 6 regions (mesio-buccal, mid-buccal, disto-buccal, mesio-lingual/palatal, mid-lingual/palatal, disto-lingual/palatal) for each tooth and recorded in millimeters (mm). The PD value for each tooth was obtained by taking the average of the 6 measured values.
Time frame: up to 4 weeks
In order to determine CAL, the cementoenamel border will be determined as a reference point and the distance between the reference point and the pocket base will be measured with a periodontal probe and recorded in mm.
CAL will be recorded from 6 regions (mesio-buccal, mid-buccal, disto-buccal, mesio-lingual/palatal, mid-lingual/palatal, disto-lingual/palatal) for each tooth. The CAL value for each tooth will be obtained by averaging the 6 measured values.
Time frame: up to 4 weeks
Plaque accumulation around the tooth will be recorded using the Plaque Index (PI) developed by Silness and Löe. Accordingly; 0. No plaque,
The PI value of each measured tooth will be obtained by averaging the scores recorded from 4 regions (mid-mesial, mid-buccal, mid-distal, mid-lingual/palatal) for a tooth. The PI value for each patient will be calculated as follows:
PI= Total PI in all teeth / Total number of teeth
Time frame: up to 4 weeks
The Probing Bleeding Index (BPI) developed by Ainamo and Bay will be used to evaluate gingival bleeding on probing.
According to this index;
Positive (+) indicates the presence of bleeding on probing,
negative (-) indicates the absence of bleeding on probing. After applying pressure by the weight of the probe within the pocket using the BPI ; periodontal probe, each tooth will be evaluated for 4 regions (mid-mesial, mid-buccal, mid-distal, mid-lingual/palatal) and will be determined as positive (+) or negative (-) and recorded as a percentage.
The percentage of bleeding on probing for each patient will be calculated as follows; BOP (bleeding on probing) percentage = number of teeth with bleeding on probing x100 / total number of teeth
Time frame: up to 2 months
RANKL concentrations of saliva samples were measured using a commercial ELISA kit (Catalog No: RE3181H, Reed Biotech, Wuhan, China) following the manufacturer's instructions. The measurement range of the kit was 15.63 pg/mL-1000 pg/mL, sensitivity was 9.38 pg/mL, and inter-assay and intra-assay CV (coefficient of variation) values were <10%. Standard solutions in the range of 15.63 pg/mL-1000 pg/mL were prepared, and the results were calculated using a curve graph. The results were given in pg/mL.
Time frame: up to 2 months
OPG concentrations of saliva samples were measured using a commercial ELISA kit (Catalog No: RE1765H, Reed Biotech, Wuhan, China) following the manufacturer's instructions. The measuring range of the kit was 0.16 ng/mL-10 ng/mL, sensitivity was 0.1 ng/mL, and inter-assay and intra-assay CV (coefficient of variation) values were <10%. Standard solutions were prepared in the range of 0.16 ng/mL-10 ng/mL, and the results were calculated using a curve graph. The results were given in ng/mL.
Time frame: up to 2 months
IL-10 concentrations of saliva samples were measured using a commercial ELISA kit (Catalog No: RE3187H, Reed Biotech, Wuhan, China) following the manufacturer's instructions. The measurement range of the kit was 1.57 pg/mL-100 pg/mL, sensitivity was 0.94 pg/mL, and inter-assay and intra-assay CV (coefficient of variation) values were <10%. Standard solutions were prepared in the range of 1.57 pg/mL-100 pg/mL, and the results were calculated using a curve graph. The results were given in pg/mL.
Time frame: up to 2 months
IL-1β concentrations of saliva samples were measured using a commercial ELISA kit (Catalog No: RE1074H, Reed Biotech, Wuhan, China) and following the manufacturer's instructions. The measurement range of the kit was 7.82 pg/mL-500 pg/mL, sensitivity was 4.69 pg/mL, and inter-assay and intra-assay CV (coefficient of variation) values were <10%. Standard solutions in the range of 7.82 pg/mL-500 pg/mL were prepared, and the results were calculated using a curve graph. The results were given in pg/mL.
Time frame: up to 2 months
Cortisol concentrations of saliva samples were measured using a commercial ELISA kit (Catalog No: RE10109, Reed Biotech, Wuhan, China) and following the manufacturer's instructions. The measuring range of the kit was 0.31 ng/mL-20 ng/mL, sensitivity was 0.9 ng/mL, and inter-assay and intra-assay CV (coefficient of variation) values were <10%. Standard solutions in the range of 0.31 ng/mL-20 ng/mL were prepared, and the results were calculated using a curve graph. The results were given in ng/mL.
Karabuk University
Other
Comparison of Salivary RANKL, OPG, IL-10, IL-1β and Cortisol Levels With Non-surgical Periodontal Treatment in Periodontitis Patients Living in Two Different Geographical Regions in Turkey
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07497828
Cytokine, Gingival Crevicular Fluid
Ordu, Turkey (Türkiye)
View Trial DetailsNCT06047132
Biomarkers, Mouth Diseases
Madrid, Spain
View Trial DetailsNCT02149758
Cyclooxygenase Two Inhibitors, Etoricoxib
Kolhāpur, Maharashtra, India
View Trial DetailsNCT07293481
Biomarker in Early Diagnosis, Mouth Diseases
Shanghai, Shanghai Municipality, China
View Trial Details